X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

Data as of 12:26pm ET
 +0.01 / +0.50%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

XTL Biopharmaceuticals Ltd. is engaged in the acquisition, development, and commercialization of proprietary and pharmaceutical products. It also develops therapeutics such as erythropoietin program, SAM-101, and diversity oriented synthesis program. These medical products are created for the treatment of multiple myeloma, schizophrenia, and hepatitis C. The company was founded on March 9, 1993 and is headquartered in Herzliya, Israel.

Contact Information

XTL Biopharmaceuticals Ltd.
Herzliya Business Park
Herzliya -- 46766
P:(729) 955-7080
Investor Relations:



Mutual fund holders1.09%
Other institutional0.02%
Individual stakeholders--

Top Executives

Joshua LevineChief Executive Officer
David KestenbaumChief Financial Officer
Moshe MittelmanMedical Director
Daniel ShapiraInternal Auditor
Navon ShalomController

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.